Publication | Closed Access

Usefulness of Preprocedural Soluble CD40 Ligand for Predicting Restenosis After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease

Percutaneous Coronary InterventionVascular DiseaseCardiovascular DiseaseMedicineMyocardial InfarctionCardiologyPublic HealthPharmacologyAtherosclerosisCoronary Artery DiseaseAcute Myocardial InfarctionCardiovascular Imaging